ASIA unversity:Item 310904400/4607
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 90587/105803 (86%)
Visitors : 16745739      Online Users : 14
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://asiair.asia.edu.tw/ir/handle/310904400/4607


    Title: Targeting ECM/Integrin Interaction with Liposome-Encapsulated Small Interfering RNAs Inhibits the Growth of Human Prostate Cancer in Bone in a Xenograft Imaging Model. Molecular Therapy
    Authors: Kristen Bisanz;Magnus Edlund;Bill Spohn;Mien-Chie Hung;Leland W. K. Chung
    Keywords: small interfering RNA;prostate cancer bone metastasis;integrins, extracellular matrix;noninvasive imaging;bioluminescence
    Date: 2005-10
    Issue Date: 2009-11-27 13:57:02 (UTC+8)
    Publisher: Asia University
    Abstract: The intricate intracellular communication between stromal and epithelial cells, which involves cell?cell-, cell?insoluble extracellular matrix- (ECM), and cell?soluble factor-mediated signaling processes, is an attractive target for therapeutic intervention in hormone-refractory and bone-metastatic prostate cancer. In the present study we demonstrated that androgen-independent PC3 prostate cancer cells adhered to and migrated on vitronectin (VN), a major noncollagenous ECM in mature bone, through the expression of v-containing integrin receptors v1 and v5 on the cell surface, as determined by antibody function blocking assay and flow cytometry analysis. Small interfering RNAs (siRNAs) targeting human integrin v markedly reduced their respective mRNA and protein expression in cells, resulting in nearly complete reduction in VN-mediated cancer progression in vitro. In vivo quantitative bioluminescence analysis of human prostate cancer bone xenografts demonstrated for the first time that intratumoral administration of liposome-encapsulated human v-siRNAs significantly inhibits the growth of luciferase-tagged PC3 tumors in skeleton, which was associated with decreased integrin v expression and increased apoptosis in tumor cells. This integrin-based gene therapy is particularly suitable for the treatment of prostate cancer bone metastasis.
    Relation: MOLECULAR THERAPY 4(12):634-643
    Appears in Collections:[Department of Biotechnology] Journal Article

    Files in This Item:

    File Description SizeFormat
    0KbUnknown509View/Open
    310904400-4607.doc33KbMicrosoft Word431View/Open


    All items in ASIAIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback